🔴 Cue Biopharma is trading 11% down with no identified company-specific catalyst

Cue Biopharma is trading 11.03% lower at $22.75 on October 5, 2026; no company-specific announcement explaining the decline was identified.

• The company’s latest listed release was its September 20 Phase 2 CUE-221 results.
• Major indexes were mixed, which does not establish a market-wide cause for the drop.
• The decline follows a sharp move lower in late September, but available evidence does not confirm a specific catalyst for today’s trading.